The world is too loud. Read what matters.

Huberman Lab

Female Testosterone Falls 1% a Year, Brain Metabolism 20% in Perimenopause

Women should establish a hormone baseline in their twenties, when testosterone is already falling about 1% a year; oral contraceptives lower ovarian cancer risk while possibly shrinking the clitoris by up to 20%; brain glucose metabolism drops 20% on average in perimenopause, and hot flashes are a disease signal, not a minor nuisance.

Female HormonesTestosteronePerimenopauseOral ContraceptivesBrain MetabolismContinuous Glucose Monitoring

The video won't play here. Listen to the audio instead:

It breaks female hormones down decade by decade, with testing windows, contraceptive risks and brain-metabolism data — a high density of counterintuitive findings. But the recommendations assume the US medical system, so you have to map them onto your own.

The argument · tap a timestamp to hear it

1:31

Set your hormone baseline in your twenties, not after symptoms appear

Taken decade by decade: in the teens the system is not yet mature, and estrogen and progesterone fluctuate too much to serve as a baseline. In your twenties you should measure estrogen, progesterone and testosterone, and also look at DHEA and the androgen pathway, because if estrogen leads the "pas de deux" it pushes up future risk of uterine fibroids and endometriosis. Timing is critical: if you can only pick one day, take day 21-22 of the cycle, roughly a week before your period; if the cycle starts getting shorter (a sign progesterone is falling), move it up to day 19-20. Blood tests are the cheapest, but dried urine gives you metabolomics and a fuller picture. Check magnesium too — magnesium is involved in clearing estrogen.

— Dr. Sara Gottfried
13:30

Testosterone starts falling as early as 28, and confidence goes first

Testosterone is the most biologically abundant hormone in a woman's body, shaping libido, muscle and the response to strength training, and also confidence, agency, even appetite for risk. It can begin declining in the twenties, as early as 28, typically by about 1% a year. The target range Gottfried gives is the upper half of the normal range. Stress and other factors change how fast the decline goes, which is why it has to be tracked rather than felt out.

— Dr. Sara Gottfried
14:50

PCOS is not a fertility-years problem, it is lifelong cardiovascular disease

PCOS is usually treated as a fertility-years problem, but it is more a lifelong cardiometabolic risk. Diagnosis requires two of three: cystic appearance on the ovaries, clinical hyperandrogenism (hirsutism, acne and so on), and menstrual cycles 35 days or shorter apart (which she explains as occasionally skipping a cycle). There are at least four sets of diagnostic criteria in the literature, which creates confusion. Gottfried points out that after 50 — average age at menopause is 51-52 — elevated testosterone and androgens are the single biggest cardiometabolic driver in women with PCOS. So PCOS management cannot stop just because the fertility years are over.

— Dr. Sara Gottfried
17:10

Normal blood sugar does not mean normal metabolism; test insulin first

In some PCOS phenotypes, hyperinsulinemia drives the ovarian theca cells to overproduce testosterone. Gottfried says she is the "biggest fan" of CGM, because no other tool changes behavior the way continuous glucose monitoring does. But she cautions that glucose is a late effect, and insulin is what should be measured first — the Whitehall study showed that post-meal insulin and vascular insulin can shift years before glucose does. She also sees CGM and other digital tools as a democratization of data: taking the chemistry of your own body back from the doctor and handing it to the patient, so people become their own clinicians.

— Dr. Sara Gottfried
21:08

Running marathons may be driving your cortisol up

Gottfried calls long-distance running and marathon-style aerobic work "chronic cardio"; when that kind of training comes without strength training, it often comes with high cortisol. Her own case: at 35 she was exhausted, carrying belly fat, with no libido for her husband, and her doctor offered only birth control pills and an antidepressant. She went out and got hormone testing instead, and found cortisol at about 3 times the normal value, fasting insulin in the 20s, blood sugar 105, mild thyroid abnormality, and low progesterone. At the time she was running four miles three or four times a week, which was pushing cortisol higher still. Only after switching to adaptive training — Pilates and more yoga — did the cortisol come down.

— Dr. Sara Gottfried
27:22

The pill really does cut ovarian cancer risk; the problem is synthetic progestin

Oral contraceptives genuinely lower ovarian cancer risk: about five years of use cuts it by 50%, because they reduce ovulation, and continuous ovulation is itself harmful. But Gottfried has strong reservations about synthetic progestin, which is in the same class as the progestin that showed problems in the Women's Health Initiative (WHI). The side effects include: high-sensitivity CRP rising about 2-3 times, which is pro-inflammatory; a more rigid HPA axis; effects on thyroid function; and oral estrogen also raises SHBG, which soaks up free testosterone like a sponge. The most extreme one: the clitoris can shrink by up to 20%. So for anyone taking the pill for acne or period pain, she advises dealing with the inflammatory root cause first, and getting informed consent without fail.

— Dr. Sara Gottfried
33:07

Hot flashes are not a nuisance, they signal falling brain metabolism

Lisa Mosconi's work at Cornell shows that the female brain undergoes enormous metabolic change starting around age 40: glucose uptake measured by FDG PET falls by about 20% on average from premenopause (age 35) through perimenopause to postmenopause. The more symptoms a woman has — hot flashes, night sweats, trouble sleeping — the more pronounced the decline in brain metabolism, which Gottfried describes as a kind of "low-level pseudo-dementia". Falling estrogen (beginning around 40-43) is thought to be the driver, and this also redefines Alzheimer's as a "midlife disease" rather than a disease of old age. Her conclusion: hot flashes and night sweats are not a minor nuisance you can ignore but biomarkers of cardiometabolic disease, bone loss and brain change; many perimenopausal symptoms are not ovary-driven but brain-driven.

— Dr. Sara Gottfried
36:54

Get a coronary calcium score before 45; no one will order it for you

Gottfried says that if a woman takes away only one thing, it should be to get a coronary artery calcium (CAC) score before age 45, and earlier if there is early-onset heart disease. The test is a chest CT, and you can order it yourself. It gives you a "fork in the road": if the score is 0 (hers is 0), you at least have a baseline; if it starts climbing around 45, or you already carry high-risk factors like PCOS, you know immediately how much attention to put into cardiometabolic health. Most conventional doctors will not order this on their own initiative; you have to ask for it.

— Dr. Sara Gottfried

In their own words · checked verbatim

women have a lot more constipation than men, the gut is about 10 feet longer in women compared to men

Dr. Sara Gottfried9:34

I've never seen any tool that I've ever used in medicine...Change behavior the way that Cgms do.

Dr. Sara Gottfried17:10

We know that if you take the oral contraceptive for about five years, it reduces your risk of ovarian cancer by 50%

Dr. Sara Gottfried22:46

it can shrink the cloris by up to 20%

Dr. Sara Gottfried28:33

Alzheimer's disease is not a disease of old age. It is disease of middle age.

Dr. Sara Gottfried33:07

it's like slow brain energy

Dr. Sara Gottfried35:00

Figures

Annual rate of testosterone decline in womenabout 1% / year14:30
Reduction in ovarian cancer risk from oral contraceptives (about 5 years)50%22:46
Clitoral shrinkage caused by oral contraceptivesup to 20%28:33
Average decline in perimenopausal brain glucose uptakeabout 20%33:07
How much longer the female intestine is than the maleabout 10 feet9:34
Share of women who have experienced significant trauma (ACE criteria)60% (men about 50%)9:34
Share of Gottfried's female patients with constipationabout 80%9:14
Women's risk of thyroid dysfunction relative to men5-8 times9:14

Glossary

SHBG / sex hormone-binding globulin
A protein that binds and lowers free estrogen and testosterone; oral contraceptives raise it.
CGM / continuous glucose monitor
A device that tracks glucose in subcutaneous tissue in real time, giving immediate feedback on how food and exercise affect blood sugar.
PCOS / polycystic ovary syndrome
A syndrome characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovaries, associated with metabolic disease.
FDG PET / fluorodeoxyglucose positron emission tomography
An imaging technique that assesses brain metabolism by tracking glucose uptake, used to observe metabolic decline.
HPA axis / hypothalamic-pituitary-adrenal axis
The neuroendocrine pathway that regulates the stress response and cortisol secretion; too much stress dysregulates it.
CAC / coronary artery calcium score
A chest CT that quantifies calcification in the coronary arteries, used to assess cardiovascular disease risk.

How to listen

Who it's for

Women who want to understand their own hormone risk curve, health coaches and physicians, and founders and product managers building women's health products.

Skip

The three sponsor segments (LMNT, AG1, Eight Sleep) can be skipped outright.